α-Synuclein Disrupts Vesicle Fusion by Two Mutant-Specific Mechanisms

被引:2
|
作者
Yoo, Gyeongji [1 ]
An, Hyeong Jeon [2 ]
Yeou, Sanghun [1 ]
Lee, Nam Ki [1 ]
机构
[1] Seoul Natl Univ, Dept Chem, Seoul 08826, South Korea
[2] Pohang Univ Sci & Technol, Dept Phys, Pohang 37673, South Korea
基金
新加坡国家研究基金会;
关键词
alpha-synuclein; familial mutant; Parkinson?s disease; VAMP2; vesicle fusion; PARKINSONS-DISEASE; PROTEIN AGGREGATION; PRESYNAPTIC PROTEIN; MEMBRANE-BINDING; LEWY BODIES; MUTATIONS; OLIGOMERS; SNARE; PERMEABILIZATION; STABILIZATION;
D O I
10.14348/molcells.2022.0102
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Synaptic accumulation of alpha-synuclein (alpha-Syn) oligomers and their interactions with VAMP2 have been reported to be the basis of synaptic dysfunction in Parkinson's disease (PD). alpha-Syn mutants associated with familial PD have also been known to be capable of interacting with VAMP2, but the exact mechanisms resulting from those interactions to eventual synaptic dysfunction are still unclear. Here, we investigate the effect of alpha-Syn mutant oligomers comprising A30P, E46K, and A53T on VAMP2-embedded vesicles. Specifically, A30P and A53T oligomers cluster vesicles in the presence of VAMP2, which is a shared mechanism with wild type alpha-Syn oligomers induced by dopamine. On the other hand, E46K oligomers reduce the membrane mobility of the planar bilayers, as revealed by single-particle tracking, and permeabilize the membranes in the presence of VAMP2. In the absence of VAMP2 interactions, E46K oligomers enlarge vesicles by fusing with one another. Our results clearly demonstrate that alpha-Syn mutant oligomers have aberrant effects on VAMP2-embedded vesicles and the disruption types are distinct depending on the mutant types. This work may provide one of the possible clues to explain the alpha-Syn mutant-type dependent pathological heterogeneity of familial PD.
引用
收藏
页码:806 / 819
页数:14
相关论文
共 50 条
  • [1] Mutant-specific gene programs in the zebrafish
    Weber, GJ
    Choe, SE
    Dooley, KA
    Paffett-Lugassy, NN
    Zhou, Y
    Zon, LI
    BLOOD, 2005, 106 (02) : 521 - 530
  • [2] KRAS mutant-specific interactions reveal mechanisms in pancreatic cancer tumorigenesis and metabolic function
    Sundararaj, Kamala
    Burge, Rachel
    Saberikashani, Samaneh
    Bialousow, Lucas
    Linke, Amanda
    Smith, Merissa
    Ostrowski, Michael C.
    O'Bryan, John P.
    Hobbs, G. Aaron
    CANCER RESEARCH, 2024, 84 (02)
  • [3] PHARMACOLOGICAL RESCUE OF MUTANT CFTR: EXPLORING MUTANT-SPECIFIC THERAPIES
    Cholon, D. M.
    Quinney, N. L.
    Chaudhry, I. G.
    Guimbellot, J. S.
    Chua, M.
    Boyles, S. E.
    Houck, S. A.
    Dokholyan, N., V
    Randell, S. H.
    Gentzsch, M.
    PEDIATRIC PULMONOLOGY, 2015, 50 : 194 - 195
  • [4] ALLOSTERIC INHIBITORS TARGET KRAS IN A MUTANT-SPECIFIC MANNER
    不详
    CANCER DISCOVERY, 2014, 4 (01) : 17 - 17
  • [5] KRAS mutant-specific protein interactions reveal mechanisms in pancreatic cancer tumorigenesis and metabolic regulation.
    Hobbs, Guy Aaron
    Burge, Rachel
    Linke, Amanda
    Sundararaj, Kamala
    O'Bryan, John P.
    CANCER RESEARCH, 2022, 82 (22) : 96 - 97
  • [6] Molecular Mechanisms of Vesicle Fusion
    Stevens, Mark J.
    Mirijanian, Dina
    BIOPHYSICAL JOURNAL, 2009, 96 (03) : 357A - 357A
  • [7] The mechanisms of vesicle budding and fusion
    Bonifacino, JS
    Glick, BS
    CELL, 2004, 116 (02) : 153 - 166
  • [8] Alpha Synuclein Inhibits Snare Mediated Vesicle Fusion
    DeWitt, David C.
    Rhoades, Elizabeth
    BIOPHYSICAL JOURNAL, 2013, 104 (02) : 51A - 51A
  • [9] THE FREQUENCY OF MUTANT-SPECIFIC KILLER PRECURSORS IN RELATED AND UNRELATED MOUSE STRAINS
    VONBOEHMER, H
    BENNINK, J
    LANGHORNE, J
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1982, 12 (10) : 892 - 895
  • [10] Targeting Mutant KRAS with Novel Mutant-Specific Pharmacological Inhibitors: Activity Against Myeloma and Other Lymphoid Malignant Cells and Molecular Mechanisms of Resistance
    Steinbrunn, Torsten
    Shirasaki, Ryosuke
    Dashevsky, Olga
    Tang, Huihui
    Yamano, Shizuka
    Mizuno, Rin
    Sugihara, Takeru
    Teoh, Phaik Ju
    Leypoldt, Lisa B.
    Kaji, Mariko
    Sorrell, Jeffrey
    Glassner, Brian J.
    Simoes, Ricardo De Matos
    Christensen, James
    Mitsiades, Constantine S.
    BLOOD, 2023, 142